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Abstract
Background: The aim of this study was to determine the success of psychotherapeutic treatment for dental phobia
by measurement of anxiety using the dental anxiety score (DAS), the state trait anxiety score (STAI state), salivary
cortisol and protein concentrations and the salivary secretion rate. Primary endpoint of the study was the
comparison of the data before and after psychotherapeutic treatment.
Methods: Forty patients were included into the study. Twenty-four were allocated to the phobic group, 16 to the
control group. Saliva was collected upon entering the dental clinic and again after three weeks of psychotherapy.
The results were compared with those of a control group. The DAS and STAI questionnaires were completed at
each visit.
Results: A reduction in DAS values was found after psychotherapy. However, the values remained significantly
higher in the phobic group than in the controls. Similar results were found for STAI scores. A slightly higher salivary
cortisol level was found in the phobic group. No changes occurred in cortisol or protein concentrations. The
salivary secretion rate increased in the phobic patients after psychotherapy.
Conclusions: It could be concluded that psychotherapy is effective in the treatment of dental phobic patients.
Trial registration: This study has been retrospectively registered in the German Clinical Trials Register (# DRKS00009552)
on 10/19/15.
Keywords: Dental phobia, Salivary cortisol, Salivary protein, Dental anxiety score, State trait anxiety score, Psychotherapy
Background
Dental anxiety is a widespread state among the popula-
tion. A recent study showed that 67 % of patients asso-
ciated visits to a dentist with anxiety [1], and 11 %
suffer from dental phobia [2]. Each anxiety state is con-
nected with physiological changes, which always result
in specific reactions of the body [1]. The terms “dental
anxiety” and “dental phobia” have been used synonym-
ously [3]. Today, dental anxiety is distinguished from
dental phobia [4]. According to the international classi-
fication of diseases (World Health Organization ICD-10
Version 2015), dental phobia is an acknowledged dis-
ease accompanied by disproportionate and sickening
fear of objects and situations that leads to avoidance
behavior, which often results in cancellation of dental
appointments [5]. Three reasons are known for the de-
velopment of dental phobia [6, 7]. The main reason is
the pain-related invasive experience during dental treat-
ment [2, 8, 9]. The second reason is learning by copy-
ing. In an investigation of 28 dental phobic patients, 22
patients said that at least one parent was a dental pho-
bic patient as well [10] or they noticed their mothers
suffering from pain during dental treatment. The third
reason is learning by instruction. Parents warn children
that dental treatment is painful. One third of dental
phobic patients develop their phobia between the ages
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of 15 and 16 years old and the other two thirds between
the ages of 18 and 26 years old [8].
Dental phobia has severe effects on the oral health sta-
tus of the patients because over years those patients
avoid visits to the dentist even avoid oral hygiene proce-
dures [11, 12]. In contrast to dental anxiety, there is a
need for psychotherapy in patients with dental phobia
prior to dental treatment [4, 13, 14]. However, there is
only scarce knowledge about the outcome of the psycho-
therapeutic treatment.
The diagnosis of dental phobia is essential because it
influences the relationship between the patient and the
dentist and has an impact on oral health [12]. Oral
health, in turn, has a great impact on personal quality
of live [15]. Subjective dental phobia is accompanied by
objective physiological symptoms (increased muscle
tension, tachycardia, sweating, stomach pain; [11]), and
motor symptoms (motionlessness, flight behavior, pan-
icking; [1]). It is possible to measure the subjective anx-
iety level with the dental anxiety scale (DAS)
questionnaire [16–18]. The DAS allows for the distin-
guishing of patients into three categories: no anxiety,
moderate anxiety and high anxiety. Dental phobic patients
belong to the third category, and they suffer from the
aforementioned symptoms. The State Trait Anxiety In-
ventory (STAI; [19, 20]) differentiates two anxiety
states: the state anxiety, which is a temporary emotional
condition, and trait anxiety, which is anxiety as a per-
sonal trait. The trait model is used to compare persons
or groups of persons; the state model measures the
effects of stress in various situations. To measure STAI
state values, a baseline is determined before stress
induction and is compared with the values after stress
induction [18–21].
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Fig. 1 Consort Flow chart of the patient allocation
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Another possibility for measuring the anxiety level is
the determination of the salivary cortisol level [22, 23].
Recent studies have shown that the salivary cortisol
level increases after acute short-term stress [23–25].
The salivary protein concentration and salivary flow
rate also play important roles in diagnosing anxiety, as
well as in overall oral health [24–27]. Therefore, these
parameters are also important markers for quantifying
dental phobia.
Psychotherapy for dental phobia comprises three differ-
ent alternative approaches: confrontation therapy, stress
coping and cognitive restructuring [4, 28]. Confrontation
therapy has been shown to be the most successful. With
this therapy, the patients are confronted repeatedly with
the anxiety-producing stimulus, which leads to a reduc-
tion in anxiety [28–30]. In stress coping therapy, patients
learn to recognize anxiety-stimulating situations and how
to address them using mental and physical relaxation ex-
ercises [4]. The cognitive restructuring method uses vid-
eos of dental treatment situations to provoke negative
feelings, which are used to develop alternative, more real-
istic thinking patterns [30, 31].
The main question of this study was to explore the ef-
fects of psychotherapy in patients with dental phobia on
their psychological and physiological parameters.
Methods
A power calculation, based on the data of a previous study
[25], was performed with a power of 0.8 and α = 0.5. The
power analysis revealed a minimum sample size of 13
subjects. As program for the power analysis Axum 7
(Mathsoft, Cambridge, Massachusetts, USA) was used.
Twenty-four patients were included in the psychotherapy
group and 16 in the control group. Of the 24 patients in
the phobic group 1 did not meet the inclusion criteria. Of
the remaining 23 patients three patients refused participa-
tion. Twenty patients entered the psychotherapy. Finally
14 patients finished the psychotherapeutic treatment and
could be followed up until saliva collection at T3. The
whole procedure is listed in Fig. 1.
Selection of patients and determination of anxiety levels
The patients suffering from dental phobia were recruited
from the Bochum dental clinic, and the control group
was recruited from the dental clinic of Witten/Herdecke
University. Patients suffering from dental phobia were
aware of their problem and visited the dental clinic be-
cause it specialized on the treatment of those patients.
All patients who visited the clinic did not suffer from
acute pain, xerostomia had no chemotherapy or radiatio.
At each visit, all the patients were asked to answer the
Fig. 2 Boxplot graphics of the DAS values of the dental phobic patients before and after psychotherapeutic treatment and of the control
patients. The score difference before and after treatment was statistically not significant (p = 0.028) at T1 but is was significant at T3 (p = 0.007).
The difference between the phobic group and the control group was significant (p < 0.001)
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State Trait Anxiety Inventory (STAI-State) [21] and
the dental anxiety scale (DAS) [16–18] to determine
their psychological anxiety levels. The indication for
psychotherapeutic interventions was based on a DAS
score > 38 in combination with avoidance of dental
treatment. In addition, the Short Form Health Survey
(SF-36) was used to determine the impact of dental
phobia on the patients’ wellbeing. The objective anx-
iety level was determined using the measured salivary
cortisol level.
Study design
The first salivary sample (T0) was collected immediately
after the patients entered the clinic. The patients were
informed that at this visit only an initial oral investiga-
tion would be carried out. The second sample was col-
lected after an initial oral investigation (determination
of the DMF-T index; T1) during the same visit. Saliva
was collected in sitting position in a quiet surrounding.
In the phobic group, psychotherapeutic treatment
followed. The psychotherapy lasted at least 3 weeks
with weekly sessions of 1 h. After finishing the psycho-
therapeutic treatment, the patients visited the dental
clinic again, and a third collection of salivary samples
followed (T2) after the initial oral investigation. After
3 months, another salivary sample was collected (T3) at
the final visit to determine the lasting effect of the psy-
chotherapeutic intervention.
Table 1 Descriptive data of the DAS values
collection time point T0 T2 T3 T0 T2 T3
Median 48.5 36 28.5 Phobic 15.5 16.5 16.5 Control
Minimum 36 19 20 12 11
Maximum 55 51 47 31 28
Quartile 25 % 43 30 23.5 15 13 37
75 % 50.25 46.25 12.75 19.75 21.5 21
p value 0.028 0.007 0.327 0.162
Fig. 3 Boxplot graphics of the STAI state score values of the dental phobic patients before and after psychotherapeutic treatment and of the
control patients. The score difference before and after treatment was statistically insignificant at T2 (p = 0.15) but it was significant at T3 (p = 0.018).
The difference between the phobic group and the control group was statistically significant (p = 0.001). The STAI score in the phobic group after
psychotherapeutic treatment remained significantly higher than that in the control group
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Psychotherapy
The psychotherapy consisted of an initial anamnestic
exploration to determine the subjective reasons for the
phobia. The patient was to obtain a sense of his or her
physiological and psychological reactions to develop
strategies for coping with stress [1]. In addition, a CD
was given to the patients that described active muscle
and stress relaxation. In the second session, experi-
ences were discussed, and the results of the dental cog-
nition questionnaire [32] were evaluated. The patients
had to develop positive thoughts to overcome the situ-
ations of anxiety and develop active coping strategies.
In the third session, the patients watched a video
demonstrating a dental treatment and discussed signs
of relapse and how to cope with them.
Saliva collection and determination of biochemical
parameters
Saliva was collected in a silent atmosphere with the
subject in a sitting position and spitting saliva into a
plastic tube for 5 min. The total amount was weighed,
and the secretion rate per minute was calculated. Then,
the samples were frozen at −800 until further use. Before
use, the saliva samples were centrifuged for 1.5 min at
525 g. Cortisol concentrations were measured using an
enzyme-linked immunosorbent assay (ELISA; RE 52611,
Table 2 Descriptive data of the STAI score values
collection time point T0 T2 T3 T0 T2 T3
Median 60 33 44 Phobic 52 2 32.5 Control
Minimum 53 23 37 37 23 25
Maximum 69 44 59 68 44 53
Quartile 25 % 54 28.25 38.5 46 27 28
75 % 67 34 48.5 65 40.25 40
p value 0.15 0.018 0.041 0.02
Fig. 4 Boxplot graphics of the salivary cortisol concentrations of the dental phobic patients before and after psychotherapeutic treatment and of
the control patients. The score difference before and after treatment was not statistically significant in either group. The difference between the
phobic group and the control group was also not significant
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IBL International, Hamburg, Germany). Protein concen-
trations were determined with Coomassie Brilliant Blue
G-250 dye [33].
Statistics
Primary endpoint of the investigation was the compari-
son between the measurement at T0, T2 and T3. Sec-
ondary endpoints were the DAS scores, STAI-state
scores, salivary secretion rate, protein concentration and
salivary cortisol concentration. As the Kruskal-Wallis
test revealed no normal distribution of the data compari-
son was calculated with the non-parametric Wilcoxon
signed-rank for related variables within the groups.
Bonferroni adjustment of the α error of 0.05 was done
and resulted in a new p value of p 0 0.025. Statistical
comparison between the groups was calculated with the
non-parametric Mann-Whitney U test for independent
variables. As statistical program served statistical package
for social sciences (SPSS, Rel. 21, IBM Corporation,
Amronk, NY, USA).
Results
There was no significant difference in the DAS at T1
after psychotherapeutic treatment (p = 0.028). At T3 the
difference in the DAS scores between both groups was
significant (p = 0.007). However, the DAS level remained
significantly (p < 0.001) higher in the phobic group than
that in the control group (Fig. 2). The data of the de-
scriptive statistics are summarized in Table 1.
Table 3 Descriptive data of the salivary cortisol concentration
collection time point T0 T2 T3 T0 T2 T3
Median 0.88 0.739 0.797 Phobic 0.634 0.54 0.545 Control
Minimum 0.401 0.062 0.25 0.291 0.218 0.415
Maximum 2.2 1.319 1.816 1.095 2.292 1.724
Quartile 25 % 0.518 0.411 0.477 0.427 0.441 0.515
75 % 1.154 0.906 1.624 0.838 0.725 0.728
p value 0.14 0.575 0.331 0.683
Fig. 5 Boxplot graphics of the salivary protein concentrations of the dental phobic patients before and after psychotherapeutic treatment and of
the control patients. The local difference in the protein concentration before and after treatment was not statistically significant in either group.
The difference between the phobic group and the control group was also not significant
Naumova et al. BMC Oral Health  (2017) 17:32 Page 6 of 10
Similar results as for the DAS score were found for
the STAI state score values. No singinificant difference
was found at T2 (p = 0.15) but at T3 (p = 0.018). The dif-
ference in the STAI state score values was significant at
all time points (p < 0.001) (Fig. 3). The data of the de-
scriptive statistics are summarized in Table 2.
Overall the salivary cortisol concentration was slightly
higher in the phobic group than in the control group
(Fig. 4), but the difference was not significant. After
psychotherapy, the cortisol level decreased slightly but
not significantly. The data of the descriptive statistics are
summarized in Table 3.
No significant changes in the salivary protein concen-
trations occurred after psychotherapy, and no differences
were detected between the phobic group and the control
group (Fig. 5). The data of the descriptive statistics are
summarized in Table 4.
The salivary secretion rate after psychotherapeutic
treatment of the dental phobic patients increased mark-
edly and was similar to that of the control group.
(Table 5 and Fig. 6). At T0 a significant difference was
found between the phobic group and the control group
(p = 0.010). At T2 and T3 no significant difference could
be observed (p 0.21 at T2 and p = 0.044 at T3).
The investigation of the DMFT index showed signifi-
cantly (p < 0.001) increased values in the phobic group
(17.36 ± 5.98) compared to the control group (2.56 ± 1.99).
Discussion
The increased DAS score in the phobic group clearly
demonstrated an increased anxiety level compared to
the control group. After psychotherapeutic treatment,
the DAS score in the group of dental phobic patients
decreased, which showed that the psychotherapeutic
intervention was successful, in accordance with the re-
sults of earlier studies [13, 14]. However, in comparing
the dental phobic group with the control group, the
DAS values of the phobic group remained significantly
higher, indicating a limited success of the psychother-
apy without equaling the control group values. This
outcome led to the conclusion that only three psycho-
therapeutic sessions and the additional exercise of
muscle relaxation would induce successive approxima-
tion of the phobic stress reaction to that of the control
group. We concluded that this short-term psychothera-
peutic intervention was useful for phobic patients, who
could return to dental practices and undergo dental in-
terventions without long-term latency after the initial
investigation. An interesting finding was that at T3 the
DAS scores and the STAI state scores were even better
than at T2 immediately after the psychotherapeutic
intervention.
The results of the STAI state values were similar to
those of the DAS values, with a slightly decreased score
value after psychotherapy. However, this difference was
not significant. Isolated analysis of the STAI state score
showing no differences before and after the psychothera-
peutic intervention could be interpreted as a mismatch
between the investigation instrument used and the stress
characteristics, such as phobia in this case. Nevertheless,
the STAI state score could be used as a screening instru-
ment for dental phobia, as shown by the significantly in-
creased values for T0 and T2 and T3 in the phobic
group compared to the control group. We concluded
Table 4 Descriptive data of the salivary protein concentrations
collection time point T0 T2 T3 T0 T2 T3
Median 3.285 2.32 2.77 Phobic 1.88 1.565 1.84 Control
Minimum 0.13 0.16 0.37 0.35 0.56 0.56
Maximum 8.81 7.3 4.71 2.8 3.26 3.04
Quartile 25 % 1.45 1.6 0.51 1.05 0.777 0.885
75 % 4.64 3.37 3.37 2.48 2.41 2.685
p value 0.272 0.091 0.875 0.509
Table 5 Descriptive data of the salivary secretion rate
collection time point T0 T2 T3 T0 T2 T3
Median 0.186 0.406 0.269 Phobic 0.395 0.521 0.555 Control
Minimum 0.084 0.126 0.087 0.13 0.171 0.063
Maximum 0.641 1.225 0.925 1.134 1.135 1.205
Quartile 25 % 0.133 0.166 0.172 0.31 0.384 0.386
75 % 0.363 0.586 0.542 0.623 0.718 0.686
p value 0.01 0.328 0.21 0.14
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that the STAI state could not be used for longitudinal
comparative studies in cohorts with dental phobia.
Taken together, both of the measurements, the DAS and
the STAI state, seemed to be valuable for the determin-
ation of anxiety level.
Both psychologic indicators the DAS score and the
STAI state score showed significant differences at T3 in
comparison with T0. This might be interpreted as a long
term effect of the psychotherapeutic intervention. A
limitation of this study is the relative high dropout rate
of the phobic patients. As dental phobic patients usually
avoid the visit of a dental office {Armfield, 2009
#1583;Willershausen, 1999 #1703}, they may also avoid
psychotherapy, because during this therapy they are con-
fronted with the situation in the dental office.
The salivary cortisol concentration in the dental pho-
bic group was slightly higher than that in the control
group, but not significantly. These findings are in ac-
cordance with another study which showed in social
phobic patients a trend towards higher cortisol levels
but not significant [23]. In contrast, in cases of acute
mental anxiety, the salivary cortisol concentration sig-
nificantly increased [25]. An explanation for this differ-
ence might be that dental phobia is more or less chronic
stress, which might have a different impact on cortisol
secretion and the plasma cortisol level. However, there
are other studies which found no correlation between
dental anxiety and the salivary cortisol level [34, 35].
Furthermore, there are not many studies which clearly
distinguished between dental anxiety and dental phobia.
Controversial results have been reported about the cor-
relation of salivary cortisol and differing stress situations
{Judd, 2016 #1888;Trueba, 2016 #1889}. The impact of
chronic and acute stress may have different effects on
the salivary cortisol level.
The slightly increased but not significant differences in
protein concentrations between the dental phobic group
and the control group were not in accordance with the
results of other studies, which showed a significantly in-
creased protein concentration in acute mental stress
subjects [24, 25, 36]. Here, the explanation might also
be that dental phobia is not an acute anxiety state.
Another study found that in subjects with acute men-
tal stress, the salivary secretion rate was not reduced
[24]. In contrast with acute mental stress patients, dental
phobia induced a decrease of the salivary secretion rate.
Regarding the positive effect of the psychotherapeutic
intervention measured by DAS, we concluded that
Fig. 6 Boxplot graphics of the salivary secretion rate of the dental phobic patients before and after psychotherapeutic treatment and of the
control patients. The difference in the secretion rate before and after psychotherapeutic treatment was not significant (p = 0.026). There was a
significant difference in salivary secretion rate between the phobic group and the control group at T0 (p = 0.010).between the control and phobic
groups. At T2 and T3 this difference was insignificant (T2 p = 0.21 and T3 p = 0.044)
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diminishing the patients’ anxiety state led to equalization
of their salivary secretion rate to that of the control group
and to improvement of the acceptance by phobic patients
of dental investigation and treatment, which might have
long-term positive effects on the DMFT score. Therefore,
longitudinal studies to investigate this aspect are needed.
The results of the DMFT score comparison are reinfor-
cing earlier studies [12]. In addition to the anxiety-
associated avoidance of dental treatment, the diminished
salivary secretion rate in patients with dental phobia could
be one possible explanation for the increased DMFT
score, as the results of earlier studies have shown [37].
Conclusions
From the results, it might be concluded that according
to the DMFT score, patients with dental phobia have re-
duced oral health. Furthermore, psychotherapeutic treat-
ment of dental phobia is effective in reducing the
anxiety state and improving the acceptance of dental
treatment by phobic patients. However, it does not reach
the level of non-phobic patients. Other than in acute
mental stress, the salivary parameters and the cortisol
and protein concentrations do not reflect changes in the
anxiety state in this study. Psychotherapeutic treatment
increases the salivary secretion rate in phobic patients to
that in non-phobic patients and improves oral health.
Therefore, measurement of the salivary secretion rate
might be a good indicator for the success of the treat-
ment. Also, STAI state determination might be a useful
tool for the recognition of patients with dental phobia,
although it is not possible to measure the long-term ef-
fects of the psychotherapeutic intervention. The DAS,
STAI state and salivary secretion rate are useful markers
for the recognition of patients with dental anxiety. Saliva
is a sensitive stress marker for dental anxiety.
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